Microbial Existentialism | GenomeWeb

If a researcher takes a swab of your nose and finds a new species of bacteria, the discovery of which leads to the development of a new drug, do you deserve a cut of those profits, asks Carl Zimmer in The New York Times. More and more, bioethicists are asking questions about people's relationships with their microbiomes, Zimmer says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.